Search

Your search keyword '"Burns, Clare L."' showing total 7 results
Start Over Author "Burns, Clare L." Journal head & neck
7 results on '"Burns, Clare L."'

4. Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change

Author

Foley, Jasmine, primary, Ward, Elizabeth C., additional, Burns, Clare L., additional, Nund, Rebecca L., additional, Wishart, Laurelie, additional, Graham, Nicky, additional, Patterson, Corey, additional, Ashley, Amy, additional, Fink, Julie, additional, Tiavaasue, Emily, additional, and Comben, Wendy, additional

Published
2021
Full Text
View/download PDF

5. Helical intensity-modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns

Author

Moroney, Laura B., primary, Helios, Jennifer, additional, Ward, Elizabeth C., additional, Crombie, Jane, additional, Pelecanos, Anita, additional, Burns, Clare L., additional, Spurgin, Ann-Louise, additional, Blake, Claire, additional, Kenny, Lizbeth, additional, Chua, Benjamin, additional, and Hughes, Brett G. M., additional

Published
2018
Full Text
View/download PDF

7. Helical intensity‐modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns.

Author

Helios, Jennifer, Crombie, Jane, Spurgin, Ann‐Louise, Moroney, Laura B., Burns, Clare L., Kenny, Lizbeth, Chua, Benjamin, Hughes, Brett G. M., Ward, Elizabeth C., Pelecanos, Anita, and Blake, Claire

Subjects
SQUAMOUS cell carcinoma, INTENSITY modulated radiotherapy, CANCER chemotherapy, PHARYNGEAL cancer, DEGLUTITION disorders, CANCER treatment
Abstract

Abstract: Background: Conformal radiotherapy modalities may minimize treatment toxicities. The purpose of this study was to document the extent and timing of dysphagia and related toxicities during helical intensity‐modulated radiotherapy (IMRT) with chemotherapy for oropharyngeal squamous cell carcinoma (SCC). Methods: We conducted a prospective study of 76 patients with oropharyngeal SCC undergoing helical IMRT with chemotherapy. Dysphagia and acute toxicity data were collected weekly during treatment and at 2, 4, and 12 weeks posttreatment using the Functional Oral Intake Scale, diet descriptors, and Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Results: Patients experienced maximum incidence of grade 3 dysphagia (61%), mucositis (30%), and thick saliva (38%), with grade 2 xerostomia (87%) and dysgeusia (97%). Only 14.5% were nil‐by‐mouth. Symptoms peaked in week 7 and improved thereafter. Grade 3 dysphagia was twice as common for T3 to T4 tumors compared with T2. Conclusion: Results confirm that patients with oropharyngeal SCC undergoing helical IMRT with chemotherapy continue to experience incidences of acute toxicities comparable with other conformal techniques, and need supportive cares. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results